Clinical Trials Browser

Phase 2 × Cognitive Dysfunction × Anticonvulsants × Clear all

NCT03356769 2020-06-09

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Phase 2 Unknown

Epilepsy, Seizures, Tuberous Sclerosis, Cognitive Dysfunction